Large-scale testing (Phase 3)Study completedNCT00811447What this trial is testingTaxotere New Indication - Gastric Cancer Treatment Registration TrialWho this might be right forStomach Neoplasms Sanofi 243
Testing effectiveness (Phase 2)Study completedNCT00062257What this trial is testingIrofulven in Treating Patients With Recurrent or Metastatic Gastric CancerWho this might be right forGastric Cancer Cancer Therapeutics Research Group
Testing effectiveness (Phase 2)Study completedNCT01283204What this trial is testingTrial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric CancerWho this might be right forRecurrent or Metastatic Gastric Cancer Yonsei University 180
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 680
Testing effectiveness (Phase 2)Study completedNCT00005599What this trial is testingBryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00991952What this trial is testingIrinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00101972What this trial is testingRAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaWho this might be right forCancer MacroGenics 53
Testing effectiveness (Phase 2)Ended earlyNCT05363605What this trial is testing[225Ac]-FPI-1966 in Participants With Advanced Solid TumoursWho this might be right forAdvanced Solid TumorHead and Neck Squamous Cell CarcinomaBladder Carcinoma+11 more Fusion Pharmaceuticals Inc. 6
Testing effectiveness (Phase 2)UnknownNCT00005876What this trial is testingNitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryWho this might be right forEsophageal CancerGastric Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00061932What this trial is testingBortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+5 more National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)UnknownNCT00985556What this trial is testingOxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerWho this might be right forGastric Cancer Yonsei University 130
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00107341What this trial is testingBortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forEsophageal Cancer Alliance for Clinical Trials in Oncology 37
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07364422What this trial is testingTo Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric CancerWho this might be right forGastric Cancer (GC) Onconic Therapeutics Inc. 49
Testing effectiveness (Phase 2)WithdrawnNCT03704077What this trial is testingAn Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric CancerCancer of the StomachStomach Cancer+1 more Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT00020787What this trial is testingVaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal CancerWho this might be right forEsophageal CancerGastric Cancer Jonsson Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00003157What this trial is testingRadiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or StomachWho this might be right forGastric CancerPancreatic Cancer Alliance for Clinical Trials in Oncology 26
Testing effectiveness (Phase 2)UnknownNCT00005607What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or EsophagusWho this might be right forEsophageal CancerGastric Cancer Robert H. Lurie Cancer Center
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24